Skip to main content

THE ADENOID CYSTIC CARCINOMA RESEARCH

EIN: 20-6745475Needham, MAZIP: 02494
H12 - Medical Research501(c)(3)

Mission

THE ADENOID CYSTIC CARCINOMA RESEARCH FOUNDATION (ACCRF) SUPPORTS RESEARCH INTO ADENOID CYSTIC CARCINOMA THAT WILL ACCELERATE THE DEVELOPMENT OF IMPROVED THERAPIES AND A CURE FOR THE DISEASE.

Financials

YearRevenueExpensesAssets
2023$1.9M$0$2.7M

Compensation

NICOLE SPARDY BURR
$0
$0
$0
$135,000
EMMA KINLOCH
$0
$0
$0
$0
RALPH MOLLIS
$0
$0
$0
$0
LISA BHAKRI
$0
$0
$0
$0
BOZHO TODORICH
$0
$0
$0
$0
THOMAS DILENGE
$0
$0
$0
$0
DAVID MORSE
$0
$0
$0
$0
ELIZABETH WEHLAGE
$0
$0
$0
$0

Similar Organizations

$2M revenue
Similar sector (H)Very similar revenue ($2M vs $1.9M)Same state (Massachusetts)Similar median compensation ($160k vs $143k)
$2.3M revenue
Similar sector (H)Similar revenue ($2.3M vs $1.9M)Same state (Massachusetts)Similar median compensation ($152k vs $143k)Similar size (11 vs 10 executives)
$2.1M revenue
Similar sector (H)Very similar revenue ($2.1M vs $1.9M)Same state (Massachusetts)Similar size (12 vs 10 executives)
$1.8M revenue
Similar sector (H)Very similar revenue ($1.8M vs $1.9M)Same state (Massachusetts)
Same sector (H12)Comparable revenue ($1M vs $1.9M)Same state (Massachusetts)
PHARE BIO INC

Boston, MA

$2.1M revenue
Similar sector (H)Similar revenue ($2.1M vs $1.9M)Same state (Massachusetts)Similar size (8 vs 10 executives)
Similar sector (H)Similar revenue ($2.2M vs $1.9M)Same state (Massachusetts)Similar size (11 vs 10 executives)
$1.5M revenue
Similar sector (H)Similar revenue ($1.5M vs $1.9M)Same state (Massachusetts)Comparable compensation levels
Reboot Rx Inc

Winchester, MA

$2.7M revenue
Similar sector (H)Comparable revenue ($2.7M vs $1.9M)Same state (Massachusetts)Similar median compensation ($160k vs $143k)Similar size (8 vs 10 executives)
$2.2M revenue
Similar sector (H)Similar revenue ($2.2M vs $1.9M)Same state (Massachusetts)Similar size (12 vs 10 executives)
Data from IRS Form 990 filings (2023).